Skip to main content

Table 14 Bivariate analysis: clinical characteristics and need for pressors

From: Serologic and urinary characteristics of laboratory-confirmed genitourinary tuberculosis at a tertiary hospital in the Philippines

Characteristic

Category

Mortality

p value

Survived

Expired

Count

Row %

Count

Row %

Gender

Male

8

15.1

45

84.9

1.000

Female

10

15.4

55

84.6

Age

0 months to 1 year

1

100.0

0

0.0

0.019

1–5 years

2

66.7

1

33.3

6–10 years

0

0.0

4

100.0

11–18 years

4

21.1

15

78.9

19–29 years

5

21.7

18

78.3

30–49 years

3

8.1

34

91.9

50–69 years

2

7.4

25

92.6

≥ 70 years

1

25.0

3

75.0

Marital status

Single/widowed

13

17.6

61

82.4

0.436

Married

5

11.4

39

88.6

Occupation

Employed

3

15.0

17

85.0

0.762

Unemployed

8

13.1

53

86.9

Not applicable

6

21.4

22

78.6

Unspecified

1

11.1

8

88.9

Location

City

10

16.1

52

83.9

0.898

Province

7

13.7

44

86.3

Unspecified

1

20.0

4

80.0

Co-morbidity

Yes

8

14.5

47

85.5

1.000

No

10

15.9

53

84.1

Diabetes mellitus

Yes

0

0.0

5

100.0

1.000

No

18

15.9

95

84.1

Hypertension

Yes

0

0.0

13

100.0

0.214

No

18

17.1

87

82.9

Chronic kidney disease

Yes

2

33.3

4

66.7

0.227

No

16

14.3

96

85.7

History of urolithiasis

Yes

2

25.0

6

75.0

0.352

No

16

14.5

94

85.5

Malignancy

Yes

0

0.0

1

100.0

1.000

No

18

15.4

99

84.6

HIV/AIDS

Yes

2

15.4

11

84.6

1.000

No

16

15.2

89

84.8

Steroid use

Yes

3

33.3

6

66.7

0.139

No

15

13.8

94

86.2

Systemic lupus erythematosus

Yes

2

25.0

6

75.0

0.352

No

16

14.5

94

85.5

Nephrotic syndrome

Yes

1

100.0

0

0.0

0.153

No

17

14.5

100

85.5

Cerebrovascular disease

Yes

0

0.0

1

100.0

1.000

No

18

15.4

99

84.6

Coronary artery disease

No

18

15.3

100

84.7

No test*

Heart failure

Yes

0

0.0

2

100.0

1.000

No

18

15.5

98

84.5

COPD

Yes

0

0.0

1

100.0

1.000

No

18

15.4

99

84.6

Bronchial asthma

Yes

0

0.0

2

100.0

1.000

No

18

15.5

98

84.5

Spina bifida

No

18

15.3

100

84.7

No test*

RTA Type 1

Yes

0

0.0

1

100.0

1.000

No

18

15.4

99

84.6

Previous TB

Yes

0

0.0

14

100.0

0.124

No

18

17.3

86

82.7

Other organ involvement of TB

Yes

15

21.4

55

78.6

0.035

No

3

6.3

45

93.8

Pulmonary TB

Yes

13

21.0

49

79.0

0.079

No

5

8.9

51

91.1

Gastrointestinal TB

Yes

10

32.3

21

67.7

0.006

No

8

9.2

79

90.8

Abdominopelvic TB

Yes

3

23.1

10

76.9

0.417

No

15

14.3

90

85.7

CNS TB

Yes

3

37.5

5

62.5

0.102

No

15

13.6

95

86.4

Bone TB

Yes

1

25.0

3

75.0

0.489

No

17

14.9

97

85.1

Cutaneous/Wound TB

Yes

3

100.0

0

0.0

0.003

No

15

13.0

100

87.0

TB Adenitis

Yes

1

10.0

9

90.0

1.000

No

17

15.7

91

84.3

Ear TB

Yes

1

50.0

1

50.0

0.283

No

17

14.7

99

85.3

Psoas TB

Yes

1

50.0

1

50.0

0.283

No

17

14.7

99

85.3

Dysuria

Yes

2

28.6

5

71.4

0.603

No

16

16.7

80

83.3

Hematuria

Yes

1

11.1

8

88.9

1.000

No

17

18.1

77

81.9

Urinary retention

Yes

0

0.0

1

100.0

1.000

No

18

17.6

84

82.4

Flank pain

Yes

1

8.3

11

91.7

0.687

No

17

18.7

74

81.3

Inguinal pain

Yes

0

0.0

1

100.0

1.000

No

18

17.6

84

82.4

Umbilical discharge

Yes

0

0.0

3

100.0

1.000

No

18

18.0

82

82.0

Fistula (uretero-cutaneous fistula)

Yes

0

0.0

1

100.0

1.000

No

18

17.6

84

82.4

Scrotal discharge

Yes

0

0.0

1

100.0

1.000

No

18

17.6

84

82.4

Double J stent reinsertion

Yes

0

0.0

1

100.0

1.000

No

18

17.6

84

82.4

Pedal edema

Yes

1

25.0

3

75.0

0.542

No

17

17.2

82

82.8

Fever

Yes

0

0.0

7

100.0

0.349

No

18

18.8

78

81.3

Weakness

Yes

2

13.3

13

86.7

1.000

No

16

18.2

72

81.8

Abdominal pain

Yes

3

27.3

8

72.7

0.402

No

15

16.3

77

83.7

Abdominal/pelvic mass on diagnostic

Yes

0

0.0

4

100.0

1.000

No

18

18.2

81

81.8

Vaginal bleeding

Yes

0

0.0

2

100.0

1.000

No

18

17.8

83

82.2

Difficulty of breathing

Yes

4

30.8

9

69.2

0.235

No

14

15.6

76

84.4

Others

Yes

4

36.4

7

63.6

0.098

No

14

15.2

78

84.8

  1. Bold values indicate statistically significant differences
  2. *No test was done since all patients were classified under the No category
  3. COPD chronic obstructive pulmonary disease, HIV/AIDS human immunodeficiency virus or acquired immunodeficiency syndrome, RTA Type 1 renal tubular acidosis Type 1, TB tuberculosis, y year